Fresche Legacy Gets $6 Million Infusion To Expand
December 7, 2015 Dan Burger
It might surprise some people to read about companies that are investing in the IBM midrange platform. After all, at least one of the top research and analysis firms has had IBM i, and before that the iSeries, and before that the AS/400, on a death watch for something like a dozen years or so. Not everyone believes that. And here’s a $6 million reason why the IBM i market is worthy of investment. When IBM i ISV Fresche Legacy looked for an investor that could give the application modernization software company a lift, it found rather quickly what it |